This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)
151 results

Relvar FAQs

Frequently asked questions on Relvar Ellipta for asthma and COPD

Relvar Ellipta Product Summary

Relvar Ellipta product information – including outline of key benefits in asthma and COPD and an introduction to Relvar mode of action

Relvar Asthma Efficacy

Relvar Ellipta summary of efficacy in asthma – including the latest data on efficacy against symptoms and exacerbations, improvements in Quality of Life and lung function

Relvar Ellipta

Fluticasone Furoate / Vilanterol</br> Respiratory

Relvar Ellipta Safety

Relvar Ellipta summary of safety – including information about active components

Volibris

Ambrisentan</br> Cardiology

Dosage and Administration

Dosage and administration information for Anoro Ellipta (umeclidinium/vilanterol), a once-daily maintenance bronchodilator treatment for breathless patients with COPD

Head-to-Head Anoro vs. Tiotropium/ Olodaterol

Learn more about the Anoro (umeclidinium/vilanterol) vs. Stiolto (tiotropium bromide/olodaterol) head-to-head data.

Efficacy and safety

An overview of clinical data for Anoro Ellipta (umeclidinium/vilanterol).

Anoro Ellipta

Respiratory

Patient Identification

Information about identifying appropriate patients for treatment with Anoro Ellipta, a maintenance treatment for patients with COPD.

Benlysta

Belimumab</br> Systemic Lupus Erythematosus

Duodart® – Dosage

Information for health professionals about Duodart® (dutasteride-tamsulosin hydrochloride) for the treatment of BPH, provided by GSK

Duodart® – Efficacy & Safety

Information for health professionals about Duodart® (dutasteride-tamsulosin hydrochloride) for the treatment of BPH, provided by GSK

Duodart

(Dutasteride/Tamsulosin HCl)</br> Urology

Duodart® – Clinical Evidence

Information for health professionals about Duodart® (dutasteride-tamsulosin hydrochloride) for the treatment of BPH, provided by GSK

About Duodart®

Duodart® is a treatment for patients with moderate-to-severe symptoms of benign prostatic hyperplasia (BPH).

Zinadol

Cefuroxime axetil</br> Antibiotics

How to Prescribe

Access the latest resources and learn how to prescribe Tivicay (dolutegravir) for the flexibility to build a tailored treatment regimen.

Slide Sets

Access the latest resources and learn how to prescribe Tivicay (dolutegravir), the only single-pill with dolutegravir at the core.

Indoxyl

Clindamycin + Benzoyl Peroxide</br> Dermatology

Indoxyl 5% vs monotherapies

Information regarding the safety and tolerability of Zinnat® (cefuroxime axetil).

Why use Benlysta?

Why Use BENLYSTA

Why Use BENLYSTA

Why Use BENLYSTA?

Managing your BENLYSTA patients

Managing BENLYSTA patients

BENLYSTA once-weekly subcutaneous injection

An overview of various articles summarising the main content of the BENLYSTA once-weekly subcutaneous injection

Safety

BENLYSTA once-weekly subcutaneous injection, safety

Administration

Administration instruction for BENLYSTA Pre-filled Pen for once-weekly subcutaneous injection

Storage and disposal

Storage and disposal instruction for BENLYSTA Pre-filled Pen for once-weekly subcutaneous injection

Flares

BENLYSTA once-weekly subcutaneous injection - Flares

Disease activity

Effect of BENLYSTA once-weekly subcutaneous injection on disease activity reduction in patients with high disease activity

Clinical trial information

Overview of BLISS-SC clinical trial

Efficacy

Overview of key efficacy points of BENLYSTA once-weekly subcutaneous injection

How BENLYSTA works

BENLYSTA selectively inhibits BLyS, an important factor in SLE

Fatigue

BENLYSTA once-weekly subcutaneous injection – Clinically meaningful improvement in fatigue

Corticosteroids

BENLYSTA once-weekly subcutaneous injection – reduction in corticosteroid use

About SRI

Description of SLE Responder Index and its components

Patient profile: Amy

Detailed description of a patient with lupus and chronic fatigue presentation, including manifestation and laboratory assessment.

Patient profile: Tina

Detailed description of a patient with lupus and new renal features, including manifestation and laboratory assessment

Patient Identification

Characteristics of patients eligible for BELYSTA once-weekly subcutaneous injection, high disease activity characteristics, clinical manifestations, concomitant medications

Patient profile: Sara

Detailed description of a patient with mucocutaneous and musculoskeletal lupus, including clinical manifestation and laboratory assessment.

Patient profile: Zoe

Detailed description of a patient with lupus and severe mucocutaneous & musculoskeletal flares, including manifestation and laboratory assessment

Benlysta

Belimumab</br> Systemic Lupus Erythematosus

BENLYSTA Safety

BENLYSTA once-weekly subcutaneous injection, safety

BENLYSTA IV Administration

Administration of BENLYSTA once-weekly subcutaneous injection

BENLYSTA Efficacy

Overview of key efficacy points of BENLYSTA once-weekly subcutaneous injection

Fluarix Tetra Safety

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Fluarix Tetra Efficacy

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Fluarix Tetra

Εμβόλιο έναντι της γρίπης</br> Vaccines

Fluarix Tetra Administration

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Fluarix Tetra Contraindications

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Fluarix Tetra Indication

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Prevention

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Population at risk

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Influenza

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Causes and transmissions

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Flu Symptoms

Fluarix Tetra influenza vaccine (split virion, inactivated) -the rationale behind the production of a quadrivalent influenza vaccine.

Population at Risk of IMD

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero

Zoom on MenB

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero, MenB

IMD Transmission

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero

Invasive Meningococcal Disease

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero

IMD Symptoms

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero

MenB Prevention

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero

Bexsero

Meningococcal group B vaccine</br> Vaccines

How to Prescribe

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine), the only single-pill with dolutegravir at the core.

Triumeq-Published Manuscripts

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine), the only single-pill with dolutegravir at the core.

Triumeq

dolutegravir/abacavir/lamivudine</br> HIV

Triumeq-Slide Sets

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine), the only single-pill with dolutegravir at the core.

Triumeq Videos

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine), the only single-pill with dolutegravir at the core.

Seretide efficacy data in paediatric asthma

Information for healthcare professionals about the clinical efficacy data for Seretide (fluticasone propionate/salmeterol xinafoate) in paediatric patients with asthma

Seretide Efficacy data in COPD

Information for healthcare professionals about the clinical efficacy data for Seretide in patients with COPD

Dosage & Administration

Guidance for health care professionals about the dosage and administration of Seretide (fluticasone propionate/salmeterol xinafoate)

Seretide efficacy data in adult asthma

Information for healthcare professionals about the clinical efficacy data for Seretide (fluticasone propionate/salmeterol xinafoate ) in adult patients with asthma

Seretide Diskus /Inhaler

σαλμετερόλη ζιναφοϊκή /φλουτικαζόνη προπιονική</br> Respiratory

Safety

Information for healthcare professionals about the safety profile of Seretide (fluticasone propionate/salmeterol xinafoate) treatment for patients with asthma or COPD

Efficacy Overview

Information for healthcare professionals about the efficacy of Seretide (fluticasone propionate/salmeterol xinafoate) treatment for patients with asthma or COPD

Augmentin

Amoxicilline & Clavulanic Acid</br> Antibiotics

Safety

Information regarding the safety and tolerability of Augmentin® (amoxicillin- clavulanate).

Efficacy

A comprehensive source of information on the efficacy of Augmentin® (amoxicillin-clavulanate), designed to help healthcare professionals in their daily practice

Patient Resources

A comprehensive list of resources to support patients who have been prescribed Augmentin® (amoxicillin-clavulanate)

Indication

Augmentin® (amoxicillin-clavulanate) is indicated for a wide range of infections. This comprehensive information is designed to help healthcare professionals in daily practice.

News & views

The most recent news and views for topics associated with Augmentin® (amoxicillin-clavulanate), to support healthcare professionals in their daily practice

Cervarix

Human Papillomavirus vaccine (types 16, 18) </br> Vaccines

Dosage & Administration

Guidance for health care professionals about preparing and administering Nucala targeted add-on asthma treatment for adult patients with severe refractory eosinophilic asthma

Disease Overview

Information for healthcare professionals about the role of eosinophils in patients with severe eosinophilic asthma, identification and associated symptoms of eosinophilic asthma

Study Summaries

Learn how Nucala, a targeted treatment for severe refractory eosinophilic asthma in adult patients works.

Nucala

Mepolizumab</br> Respiratory

Introducing Nucala

Information for healthcare professionals about prescription medicine Nucala, the first targeted anti-IL-5 add-on therapy for your adult patients with severe refractory eosinophilic asthma

Practical Tools

Online tools for healthcare professionals to identify if your severe refractory asthma patient may be eligible to receive Nucala, the first targeted anti-IL-5 add-on therapy for your adult patients with severe refractory eosinophilic asthma

Patient Identification

Information for healthcare professionals about identifying adult patients with severe refractory eosinophilic asthma who may benefit from targeted anti-IL-5 add-on treatment with Nucala

show more